ArticleBMC gastroenterology2026

Real-world comparison of GLP-1 agonists versus physical activity in metabolic dysfunction-associated steatotic liver disease.

Jason N Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.